Low‑dose trametinib and Bcl‑xL antagonist have a specific antitumor effect in KRAS‑mutated colorectal cancer cells
Makoto Koyama(Shinshu University), Yuji Soejima(Shinshu University)
Cited by 10
Related Papers
Sesamin, a lignan of sesame, down‐regulates cyclin D1 protein expression in human tumor cells
|Cancer Science|2007|150
Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS<sup>G12D</sup>Inhibitor, in Colorectal Cancer Treatment
|Anticancer Research|2023|22
MEK inhibitor and anti-EGFR antibody overcome sotorasib resistance signals and enhance its antitumor effect in colorectal cancer cells
|Cancer Letters|2023|21
Impact of endothelial nitric oxide synthase activation on accelerated liver regeneration in a rat ALPPS model
|World Journal of Gastroenterology|2023|3